Collagen type II (Col2a1), linked with HLA-DRB1/DRA1 expression, has been used to target and eliminate CII-specific CD4 T cells, reducing RA in murine models (41). This evidence concerns the gene HLA-DRB1 and rheumatoid arthritis.